• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据疾病严重程度对慢性阻塞性肺疾病(COPD)的患病率、诊断不足情况以及吸烟的归因比例:来自瑞典北部阻塞性肺病研究的报告

Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.

作者信息

Lindberg Anne, Bjerg A, Rönmark Eva, Larsson Lars-Gunnar, Lundbäck Bo

机构信息

The OLIN studies, Department of Medicine, Sunderby Central Hospital of Norrbotten, SE-971 80 Luleå, Sweden.

出版信息

Respir Med. 2006 Feb;100(2):264-72. doi: 10.1016/j.rmed.2005.04.029. Epub 2005 Jun 21.

DOI:10.1016/j.rmed.2005.04.029
PMID:15975774
Abstract

BACKGROUND

There is a lack of epidemiological data on COPD by disease severity. We have estimated the prevalence and underdiagnosis of COPD by disease severity defined by the British Thoracic Society (BTS) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. The impact of smoking was evaluated by the population attributable fraction of smoking in COPD.

METHODS

A random sample of 1500 responders of the third postal survey performed in 1996 of the Obstructive Lung Disease in Northern Sweden (OLIN) Studies' first cohort (6610 subjects recruited in 1985) were invited to structured interview and spirometry. One thousand two hundred and thirty-seven subjects (82%) performed spirometry.

RESULTS

The prevalence of mild BTS-COPD was 5.3%, moderate 2.2%, and severe 0.6% (GOLD-COPD: mild 8.2%, moderate 5.3%, severe 0.7%, and very severe 0.1%). All subjects with severe COPD were symptomatic, corresponding figures among mild COPD were 88% and 70% (BTS and GOLD), Subjects with severe BTS-COPD reported a physician-diagnosis consistent with COPD in 50% of cases, in mild BTS-COPD 19%, while in mild GOLD-COPD only 5% of cases. The major risk factors, age and smoking, had a synergistic effect on the COPD-prevalence. The Odds Ratio (OR) for having COPD among smokers aged 76-77 years was 59 and 34 (BTS and GOLD) when non-smokers aged 46-47 was used as reference population.

CONCLUSIONS

Most subjects with COPD have a mild disease. The underdiagnosis is related to disease-severity. Though being symptomatic, only a half of the subjects with severe COPD are properly labelled. Smoking and increasing age were the major risk factors and acted synergistic.

摘要

背景

目前缺乏按疾病严重程度划分的慢性阻塞性肺疾病(COPD)的流行病学数据。我们根据英国胸科学会(BTS)和慢性阻塞性肺疾病全球倡议组织(GOLD)指南所定义的疾病严重程度,估算了COPD的患病率及诊断不足情况。通过吸烟在COPD中的人群归因分数评估了吸烟的影响。

方法

在瑞典北部阻塞性肺疾病(OLIN)研究的第一个队列(1985年招募6610名受试者)1996年进行的第三次邮政调查中,随机抽取1500名应答者,邀请他们接受结构化访谈和肺活量测定。1237名受试者(82%)进行了肺活量测定。

结果

轻度BTS-COPD的患病率为5.3%,中度为2.2%,重度为0.6%(GOLD-COPD:轻度8.2%,中度5.3%,重度0.7%,极重度0.1%)。所有重度COPD患者均有症状,轻度COPD患者中相应比例在BTS和GOLD标准下分别为88%和70%。重度BTS-COPD患者中50%报告医生诊断与COPD相符,轻度BTS-COPD患者中为19%,而轻度GOLD-COPD患者中仅为5%。主要危险因素年龄和吸烟对COPD患病率有协同作用。以46-47岁非吸烟者为参照人群时,76-77岁吸烟者患COPD的比值比(OR)在BTS和GOLD标准下分别为59和34。

结论

大多数COPD患者病情较轻。诊断不足与疾病严重程度有关。尽管有症状,但重度COPD患者中只有一半得到正确诊断。吸烟和年龄增长是主要危险因素且具有协同作用。

相似文献

1
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.根据疾病严重程度对慢性阻塞性肺疾病(COPD)的患病率、诊断不足情况以及吸烟的归因比例:来自瑞典北部阻塞性肺病研究的报告
Respir Med. 2006 Feb;100(2):264-72. doi: 10.1016/j.rmed.2005.04.029. Epub 2005 Jun 21.
2
Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.慢性阻塞性肺疾病可逆性测试对患病率及危险因素的影响:一项社区研究
Thorax. 2005 Oct;60(10):842-7. doi: 10.1136/thx.2005.043943. Epub 2005 Aug 5.
3
Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.根据英国胸科学会(BTS)、欧洲呼吸学会(ERS)、慢性阻塞性肺疾病全球倡议(GOLD)和美国胸科学会(ATS)标准,慢性阻塞性肺疾病的患病率与医生诊断、症状、年龄、性别及吸烟习惯的关系
Respiration. 2005 Sep-Oct;72(5):471-9. doi: 10.1159/000087670.
4
Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.不是15%而是50%的吸烟者会患慢性阻塞性肺疾病?——来自瑞典北部阻塞性肺病研究的报告。
Respir Med. 2003 Feb;97(2):115-22. doi: 10.1053/rmed.2003.1446.
5
COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.非吸烟人群中的 COPD - 来自瑞典北部阻塞性肺病(OLIN)研究的报告。
Respir Med. 2012 Jul;106(7):980-8. doi: 10.1016/j.rmed.2012.03.010. Epub 2012 Apr 11.
6
COPD 'diagnosis' based on spirometric reference equations.基于肺量计参考方程的慢性阻塞性肺疾病“诊断”
Clin Respir J. 2008 Oct;2(4):214-9. doi: 10.1111/j.1752-699X.2008.00065.x.
7
Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.有呼吸道症状队列中,第一秒用力呼气容积(FEV1)下降与慢性阻塞性肺疾病发病的关系
COPD. 2007 Mar;4(1):5-13. doi: 10.1080/15412550601168358.
8
Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.以色列45岁及以上吸烟者中慢性阻塞性肺疾病的患病率。
Isr Med Assoc J. 2007 Nov;9(11):800-2.
9
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].[德国慢性阻塞性肺疾病(COPD)的患病率。BOLD研究结果]
Dtsch Med Wochenschr. 2008 Dec;133(50):2609-14. doi: 10.1055/s-0028-1105858. Epub 2008 Dec 3.
10
Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.40至65岁男性吸烟者中中度慢性阻塞性肺疾病(GOLD II级)的发病率及影响因素:5年随访
Br J Gen Pract. 2006 Sep;56(530):656-61.

引用本文的文献

1
Risk and Protective Factors of COPD Among Smokers: A Cross-Sectional Study Using NHANES Database.吸烟者中慢性阻塞性肺疾病的风险和保护因素:一项使用美国国家健康与营养检查调查(NHANES)数据库的横断面研究。
Int J Chron Obstruct Pulmon Dis. 2025 Apr 11;20:1027-1038. doi: 10.2147/COPD.S489581. eCollection 2025.
2
Phenotyping Exertional Breathlessness Using Cardiopulmonary Cycle Exercise Testing in People With Chronic Airflow Limitation.在慢性气流受限患者中使用心肺循环运动测试对运动性呼吸困难进行表型分析。
Chest. 2025 Aug;168(2):379-389. doi: 10.1016/j.chest.2025.02.033. Epub 2025 Mar 11.
3
Identifying Abnormal Exertional Breathlessness in COPD: Comparing Modified Medical Research Council and COPD Assessment Test With Cardiopulmonary Exercise Testing.
识别慢性阻塞性肺疾病(COPD)患者异常运动性呼吸困难:改良医学研究委员会问卷与COPD评估测试对比心肺运动试验
Chest. 2025 Mar;167(3):697-711. doi: 10.1016/j.chest.2024.10.027. Epub 2024 Oct 28.
4
COPD is associated with increased cardiovascular disease risk independent of phenotype.COPD 与心血管疾病风险增加相关,而与表型无关。
Respirology. 2024 Dec;29(12):1047-1057. doi: 10.1111/resp.14799. Epub 2024 Jul 17.
5
All-cause and cause-specific mortality by spirometric pattern and sex - a population-based cohort study.基于肺活量测定模式和性别的全因死亡率及特定病因死亡率——一项基于人群的队列研究
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241232768. doi: 10.1177/17534666241232768.
6
Perspectives and Attitudes of General Practitioners Towards Pharmacological and Non-Pharmacological COPD Management in a Belgian Primary Care Setting: A Qualitative Study.全科医生在比利时初级医疗环境中对 COPD 药物和非药物管理的观点和态度:一项定性研究。
Int J Chron Obstruct Pulmon Dis. 2023 Sep 25;18:2105-2115. doi: 10.2147/COPD.S423279. eCollection 2023.
7
The modified Borg/6-min walk distance ratio: a method to assess exertional breathlessness and leg discomfort using the 6-min walk test.改良版博格/6分钟步行距离比值:一种使用6分钟步行试验评估运动性呼吸困难和腿部不适的方法。
ERJ Open Res. 2023 Sep 25;9(5). doi: 10.1183/23120541.00281-2023. eCollection 2023 Sep.
8
The Experiences of Close Relatives to Women with Chronic Obstructive Pulmonary Disease Stages III or IV: A Qualitative Study.慢性阻塞性肺疾病Ⅲ或Ⅳ期女性患者近亲的经历:一项定性研究
Nurs Rep. 2023 Jul 15;13(3):982-989. doi: 10.3390/nursrep13030086.
9
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers.肝脏、胆囊和胆管癌个人合并症的人群归因分数
Cancers (Basel). 2023 Jun 7;15(12):3092. doi: 10.3390/cancers15123092.
10
Striving for moments of easier breathing despite being trapped in breathlessness: meanings of feeling well for women with chronic obstructive pulmonary disease stage III or IV.尽管被困在呼吸困难中,仍努力争取呼吸更轻松的时刻:慢性阻塞性肺疾病 III 或 IV 期女性感觉良好的意义。
Int J Qual Stud Health Well-being. 2023 Dec;18(1):2225937. doi: 10.1080/17482631.2023.2225937.